MERYX
Meryx is a biotechnology company that develops orally bio-available cancer drugs targeting receptor tyrosine kinases. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancers such as leukemia, lung cancer, and melanoma. It offers potent inhibitors of MerTK, such as MRX-2843, a clinical drug candidate; and MRX-6313, a backup candidate that inhibit growth and initiate anti-tumor immunity in a range of hematologic and solid malignancies. Meryx was founded in 2013 and is based in Chapel Hill, North Carolina.
MERYX
Industry:
Biotechnology Medical Medical Device
Founded:
2013-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Website Url:
http://www.meryxpharma.com
Total Employee:
1+
Status:
Active
Contact:
(919) 985-7821
Total Funding:
5.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS DreamHost Hosting Dreamhost DNS Meteor
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
H. Shelton Earp Co-Founder and Member @ Meryx
Co-Founder and Member
Douglas Graham Co-Founder and Member @ Meryx
Co-Founder and Member
Stephen Frye Co-Founder and Member @ Meryx
Co-Founder and Member
Founder
Official Site Inspections
http://www.meryxpharma.com
- Host name: apache2-cabo.iad1-shared-b7-24.dreamhost.com
- IP address: 67.205.5.96
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Meryx"
Meryx - Crunchbase Company Profile & Funding
Meryx is a biotechnology company that develops orally bio-available cancer drugs targeting receptor tyrosine kinases. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancers such as …See details»
Meryx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Meryx, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, Disease Domain:Hemic and Lymphatic Diseases, Immune System Diseases, Neoplasms, …See details»
Meryx Company Profile 2024: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Meryx.See details»
Meryx - Ownership and Business Overview | Mergr
Dec 7, 2021 · Meryx is a clinical stage immuno-oncology company focused on advancing small molecule, orally bioavailable inhibitors of Mer Receptor Tyrosine Kinase (RTK) that inhibit …See details»
Meryx Inc. - VentureRadar
Website: http://www.meryxpharma.com. Meryx is developing small-molecule, orally-bioavailable RTK inhibitors that inhibit growth and initiate anti-tumor immunity in hematologic and solid …See details»
Meryx Inc. Company Profile | Chapel Hill, NC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Meryx Inc. of Chapel Hill, NC. Get the latest business insights from Dun & Bradstreet.See details»
Meryx - Products, Competitors, Financials, Employees, …
Meryx is a clinical-stage immuno-oncology company focused on advancing small molecule, orally bioavailable inhibitors of Mer Receptor Tyrosine Kinase (RTK) that inhibit growth and initiate …See details»
Meryx Inc. - CAGE.report
Nov 13, 2017 · https://www.meryxpharma.com. Contact Person: Stephen Frye County Code (3 digit): 135 Congressional District: 04 Metropolitan Statistical Area: 6640 CAGE Code: 71PC6 …See details»
Meryx Inc. Asset Profile | Preqin
Established in 2013 and based in North Carolina, US, Meryx Inc. operates as a biotechnology company that develops orally bioavailable drugs for cancer diseases such as leukemia, lung …See details»
Meryx’s Competitors, Revenue, Number of Employees, Funding
Meryx’s Profile, Revenue and Employees. Meryx is a North Carolina-based biotechnology company that develops and commercializes small molecule therapies for the treatment of …See details»
Meryx Pharma - Company Profile - Tracxn
Sep 20, 2024 · Meryx is developing orally bioavailable cancer drugs targeting receptor tyrosine kinases with the potential to both inhibit tumor growth and initiate anti-tumor immunity in a …See details»
Meryx Company Profile - Office Locations, Competitors, Revenue …
Meryx has 1 employees at their 1 location. See insights on Meryx including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Xcovery Acquires Majority Controlling Stake in Meryx ... - BioSpace
Dec 7, 2021 · Meryx, Inc. is a clinical stage immuno-oncology company focused on advancing small molecule, orally bioavailable inhibitors of Mer Receptor Tyrosine Kinase (RTK) that …See details»
Xcovery Acquires Majority Controlling Stake in Meryx …
Dec 7, 2021 · PALM BEACH GARDENS, Fla.-- ( BUSINESS WIRE )-- Xcovery Holdings, Inc., an oncology focused bio-pharmaceutical company, is proud to announce the acquisition of a …See details»
Xcovery Acquires Majority Controlling Stake in Meryx …
Dec 8, 2021 · Xcovery Holdings, Inc., an oncology focused bio-pharmaceutical company, is proud to announce the acquisition of a majority and controlling stake in Meryx Inc., a clinical stage …See details»
Xcovery Acquires Majority Controlling Stake in Meryx …
Dec 7, 2021 · PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–Xcovery Holdings, Inc., an oncology focused bio-pharmaceutical company, is proud to announce the acquisition of a …See details»
About Us - Emery Pharma
Emery Pharma is a full-service contract research organization (CRO) that supports the end-to-end development of small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.See details»
Xcovery Acquires Majority Controlling Stake in Meryx …
Dec 7, 2021 · PALM BEACH GARDENS, Fla.-- (BUSINESS WIRE)-- Xcovery Holdings, Inc., an oncology focused bio-pharmaceutical company, is proud to announce the acquisition of a …See details»
Emery Pharma Contract Research Laboratory Organization (CRO)
Emery Pharma is a full-service Contract Research Organization (CRO) that delivers customized solutions with a range of services and leadership expertise to accelerate life science innovations.See details»
Emery Pharma and Marin Biologic Laboratories Announce …
Sep 10, 2024 · Alameda, CA, and Novato, CA – September 10, 2024 – Emery Pharma, a leader in bioanalytical chemistry, mass spectrometry, and CMC services, and Marin Biologic …See details»